CSS LLC’s Quest Diagnostics DGX Stock Holding History

CSS LLC’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,000	Closed	-$965K	–	852
2023 Q4	$965K	Buy	+7,000	New	+$920K	0.06%	260

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CSS LLC's DGX Position: Q2 2024 in Review

CSS LLC sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 3,500 shares — an estimated $466K sold.

CSS LLC first reported a position in DGX in Q2 2022 and held it in 3 quarters. The position peaked at $591K in Q2 2022. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

CSS LLC reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
CSS LLC sold 3,500 Quest Diagnostics shares in Q2 2024, an estimated $466K.
CSS LLC first reported a position in Quest Diagnostics in Q2 2022 and held it in 3 quarters.
CSS LLC's Quest Diagnostics position peaked at $591K in Q2 2022.
838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on CSS LLC's 13F filing for Q2 2024, filed 14 Aug 2024.